Amgen, Inc. (AMGN)
337.09
+0.64
(+0.19%)
USD |
NASDAQ |
May 14, 12:02
Amgen Shareholders Equity (Quarterly) : 9.19B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Gilead Sciences, Inc. | 23.52B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| AbbVie, Inc. | -6.656B |
| Moderna, Inc. | 7.408B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.50B |
| Total Liabilities (Quarterly) | 83.31B |
| Debt to Equity Ratio | 6.238 |
| Current Ratio | 1.261 |
| Net Debt Paydown Yield | 0.37% |